First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Giuseppe Colucci, Vito Lorusso et al.|Lung Cancer|2009Cited by 18
Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast CancerGiulio Metro, Alessandra Fabi, Francesco Cognetti et al.|The Breast Journal|2009Cited by 11
Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II StudyVito Lorusso, Mario De Lena, Bernardo Leone et al.|Gynecologic Oncology|1998Cited by 5
Impact of Anemia Management with EPO on Psychologic Distress in Cancer Patients: Results of a Multicenter Patient SurveySalvatore Del Prete, Raffaele Addeo, Saverio Cinieri et al.|Future Oncology|2013Cited by 2
First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Giuseppe Colucci, Vito Lorusso et al.|European Journal of Cancer Supplements|2008Cited by 0